Bee Vectoring Technologies Has Multiple Revenue Streams

Sergio Heiber profile picture
Sergio Heiber


  • BVT has expanded beyond its initial territories and added new crops.
  • The company has broadened its product application for potential collaboration with agricultural industry giants.
  • BVT has entered its first contract with a third-party agricultural company.
  • Revenues should at least double over the next year and scale more rapidly in subsequent years as multiple revenue sources are developed.

Bumblebee visiting blueberry bush in bloom

Scharvik/iStock via Getty Images

(All figures in this article are in Canadian dollars unless otherwise stated.)

Bee Vectoring Technologies (OTCQB:BEVVF) offers patented bee-delivered crop protection and fertilizer system consisting of a fungicide, CR-7, sold along with a beehive system and

This article was written by

Sergio Heiber profile picture
I write about and invest in mostly early commercial stage companies that have a large TAM and zero to little direct competition. I will provide updates on companies that I introduce as long as the goalposts set by management are met. Of course, there are always unforeseen developments more often in the microcap world than otherwise and there are macro conditions that are beyond the control of company management. I'm also not always right but I like the risk/reward characteristics of investing in micro-caps.My articles are reflective of my investment interests and hopefully provide readers with ideas that they can further explore. I tend to be on the long side and generally abstain from writing negative or short themes. Besides my articles on SA, readers can find my work at and

Disclosure: I/we have a beneficial long position in the shares of BEVVF either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Recommended For You

Comments (17)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.